Skip to main content
OpenTrials
Completed

NCT Number: NCT00909051

GlucoVIP - Diabetes Treatment by Glucobay® With a Special Therapeutic View to Chosen Patient Groups

Evaluation of safety and effectiveness of Glucobay® under daily-life treatment conditions in a large sample of patients.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Multiple Locations, Algeria

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with untreated or pretreated diabetes mellitus or patients for which acarbose is indicated and without acarbose treatment within the last three months before study inclusion. The decision for treatment type and duration is taken by the investigator and is made before inclusion into the study.

Exclusion criteria

  • Exclusion criteria must be read in conjunction with the local product information.

Treatment and study plan

Acarbose (Glucobay, BAYG5421)

Drug

Patients with diabetes type 2 newly treated with Glucobay

Primary outcomes

  1. Data collection on patients weight and waist circumference, fasting blood glucose, postprandial blood glucose (2h), HbA1C; exploratory analysis according to patient groups (concomitant cardiovascular disease groups, BMI)

    Time frame: During observation period of three months

Sponsors and collaborators

Lead sponsor

Bayer

Industry

Registry information

Official study title

Diabetes Treatment by Glucobay® With a Special Therapeutic View to Chosen Patient Groups

Important dates

Study start
2009
Primary completion
2010
Study completion
2010
First posted
May 27, 2009
Registry last updated
Jun 6, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.